Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a major regulator of the oxidative stress response and it is negatively regulated by Kelch-like ECH-associated protein 1 (Keap1). The Keap1–Nrf2 axis has a fundamental role in carcinogenesis. In previous studies, the widely used diabetes drug met...
Main Authors: | Elina Urpilainen, Jenni Kangaskokko, Ulla Puistola, Peeter Karihtala |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2019-01-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428318815413 |
Similar Items
-
No Association Between Statin Use and the Prognosis of Endometrial Cancer in Women With Type 2 Diabetes
by: Elina Urpilainen, et al.
Published: (2021-05-01) -
The role of metformin and statins in ovarian and breast cancer in women with type 2 diabetes
by: Urpilainen, E. (Elina)
Published: (2019) -
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
by: Elina Urpilainen, et al.
Published: (2018-07-01) -
Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes
by: Mayu Hosio, et al.
Published: (2021-05-01) -
Oxidative damage and counteracting mechanisms in breast carcinoma
by: Karihtala, P. (Peeter)
Published: (2006)